Colleen M. Connelly

Colleen M. Connelly

Auto-generated profile, based on publicly available information

Colleen M. Connelly

Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Cell Chemical Biology
Verified
Journal Article
Closed access
CCColleen M. Connelly
Colleen M. Connelly
MMMichelle H. Moon
Michelle H. Moon
JJJohn S. Schneekloth, Jr
John S. Schneekloth, Jr

19 May 2010 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
DYDouglas D. Young
Douglas D. Young
CCColleen M. Connelly
Colleen M. Connelly
CGChristoph Grohmann
Christoph Grohmann
ADAlexander Deiters
Alexander Deiters

23 December 2016 in ACS Chemical Biology
Verified
Journal Article
Closed access
CCColleen M. Connelly
Colleen M. Connelly
RBRobert E. Boer
Robert E. Boer
MMMichelle H. Moon
Michelle H. Moon
PGPeter Gareiss
Peter Gareiss
JJJohn S. Schneekloth, Jr
John S. Schneekloth, Jr

1 July 2012 in SLAS Discovery
Verified
Journal Article
Open access
PDF file
CCColleen M. Connelly
Colleen M. Connelly
MTMeryl Thomas
Meryl Thomas
ADAlexander Deiters
Alexander Deiters
MicroRNAs (miRNAs) are endogenous, single-stranded, noncoding RNAs of 21 to 23 nucleotides that regulate gene expression, typically by binding the 3′ untranslated regions of target messenger RNAs. It is estimated that miRNAs are involved in the regulation of 30% of all genes and almost every genetic pathway. Recently, the misregulation of miRNAs has been linked to various human diseases including cancer and viral infections, identifying miRNAs as potential targets for drug discovery. Thus, small-molecule modifiers of miRNAs could serve as lead structures for the development of new therapeutic agents and be useful tools in the elucidation of detailed mechanisms of miRNA function. As a result, we have developed a high-throughput screen for potential small-molecule regulators of the liver-specific microRNA miR-122, which is involved in hepatocellular carcinoma development and hepatitis C virus infection. Our small-molecule screen employs a Huh7 human hepatoma cell line stably transfected with a Renilla luciferase sensor for endogenous miR-122. The assay was optimized and validated using an miR-122 antisense agent and a previously identified small-molecule miR-122 inhibitor. The described reporter assay will enable the high-throughput screening of small-molecule miR-122 inhibitors and can be readily extended to other miRNAs.

3 September 2012 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
CCColleen M. Connelly
Colleen M. Connelly
RURajendra Uprety
Rajendra Uprety
JHJames Hemphill
James Hemphill
ADAlexander Deiters
Alexander Deiters
MicroRNAs (miRNAs) are small non-coding RNAs that act as post-transcriptional gene regulators and have been shown to regulate many biological processes including embryonal development, cell differentiation, apoptosis, and proliferation. Variations in the expression of certain miRNAs have been linked to a wide range of human diseases – especially cancer – and the diversity of miRNA targets suggests that they are involved in various cellular networks. Several tools have been developed to control the function of individual miRNAs and have been applied to study their biogenesis, biological role, and therapeutic potential; however, common methods lack a precise level of control that allows for the study of miRNA function with high spatial and temporal resolution. Light-activated miRNA antagomirs for mature miR-122 and miR-21 were developed through the site-specific installation of caging groups on the bases of selected nucleotides. Installation of caged nucleotides led to complete inhibition of the antagomir-miRNA hybridization and thus inactivation of antagomir function. The miRNA-inhibitory activity of the caged antagomirs was fully restored upon decaging through a brief UV irradiation. The synthesized antagomirs were applied to the photochemical regulation of miRNA function in mammalian cells. Moreover, spatial control over antagomir activity was obtained in mammalian cells through localized UV exposure. The presented approach enables the precise regulation of miRNA function and miRNA networks with unprecedented spatial and temporal resolution using UV irradiation and can be extended to any miRNA of interest.

6 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
SBSumirtha Balaratnam
Sumirtha Balaratnam
CRCurran Rhodes
Curran Rhodes
DBDesta Doro Bume
Desta Doro Bume
CCColleen Connelly
Colleen Connelly
CLChristopher C. Lai
Christopher C. Lai
JJJohn S. Schneekloth, Jr
John S. Schneekloth, Jr
The role of metabolite-responsive riboswitches in regulating gene expression in bacteria is well known and makes them useful systems for the study of RNA-small molecule interactions. Here, we study the PreQ1 riboswitch system, assessing sixteen diverse PreQ1-derived probes for their ability to selectively modify the class-I PreQ1 riboswitch aptamer covalently. For the most active probe (11), a diazirine-based photocrosslinking analog of PreQ1, X-ray crystallography and gel-based competition assays demonstrated the mode of binding of the ligand to the aptamer, and functional assays demonstrated that the probe retains activity against the full riboswitch. Transcriptome-wide mapping using Chem-CLIP revealed a highly selective interaction between the bacterial aptamer and the probe. In addition, a small number of RNA targets in endogenous human transcripts were found to bind specifically to 11, providing evidence for candidate PreQ1 aptamers in human RNA. This work demonstrates a stark influence of linker chemistry and structure on the ability of molecules to crosslink RNA, reveals that the PreQ1 aptamer/ligand pair are broadly useful for chemical biology applications, and provides insights into how PreQ1, which is similar in structure to guanine, interacts with human RNAs.